000 | 01899 a2200493 4500 | ||
---|---|---|---|
005 | 20250516180839.0 | ||
264 | 0 | _c20141104 | |
008 | 201411s 0 0 eng d | ||
022 | _a1873-5177 | ||
024 | 7 |
_a10.1016/j.pbb.2013.10.030 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBleickardt, Carina J | |
245 | 0 | 0 |
_aAntagonism of the adenosine A2A receptor attenuates akathisia-like behavior induced with MP-10 or aripiprazole in a novel non-human primate model. _h[electronic resource] |
260 |
_bPharmacology, biochemistry, and behavior _cMar 2014 |
||
300 |
_a36-45 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdenosine A2 Receptor Antagonists _xpharmacology |
650 | 0 | 4 |
_aAkathisia, Drug-Induced _xdrug therapy |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntipsychotic Agents _xadministration & dosage |
650 | 0 | 4 | _aAripiprazole |
650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
650 | 0 | 4 | _aCebus |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHaloperidol _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMotor Activity _xdrug effects |
650 | 0 | 4 |
_aPhosphodiesterase Inhibitors _xadministration & dosage |
650 | 0 | 4 |
_aPiperazines _xadministration & dosage |
650 | 0 | 4 |
_aPyrazoles _xadministration & dosage |
650 | 0 | 4 |
_aPyrimidines _xpharmacology |
650 | 0 | 4 |
_aQuinolines _xadministration & dosage |
650 | 0 | 4 |
_aQuinolones _xadministration & dosage |
650 | 0 | 4 |
_aTriazoles _xpharmacology |
700 | 1 | _aKazdoba, Tatiana M | |
700 | 1 | _aJones, Nicholas T | |
700 | 1 | _aHunter, John C | |
700 | 1 | _aHodgson, Robert A | |
773 | 0 |
_tPharmacology, biochemistry, and behavior _gvol. 118 _gp. 36-45 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.pbb.2013.10.030 _zAvailable from publisher's website |
999 |
_c23248168 _d23248168 |